Branded Legacy, Inc. Signs Letter of Intent to Acquire a Mycology Research Lab
Company Executes Immediate Action Plan
MELBOURNE, Fla., July 18, 2023 /PRNewswire/ — Branded Legacy, Inc. (OTC-PINK: BLEG), a holding company specializing in growth through acquisitions with a focus on the Biotechnology sector, announced today that is has a signed letter of intent to acquires Mycoenlighten, a mycology research lab that specializes in alkaloid extraction, purification, and synthesis.
Related news for (BLEG)
- Branded Legacy, Inc. Strengthens Biotech Leadership, Focuses on Expansion, and Advances Strategic Rebranding
- Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement
- Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count
- Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion
- Branded Legacy, Inc. Unveils Strategic Transformation in Investor Teleconference